Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.
Press releases published on April 3, 2025
Augmentation de la demande en matière d’emploi en Alberta jusqu’en 2034, la croissance étant la plus forte dans le secteur non résidentiel
GlobeNewswire
·
April 3, 2025
OTTAWA, Ontario, 03 avr. 2025 (GLOBE NEWSWIRE) -- En 2024, le secteur de la construction de l’Alberta a connu une croissance dans les secteurs résidentiel et non résidentiel et a enregistré des augmentations des investissements par rapport à l’année …
Gencor Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenues Up 20%
GlobeNewswire
·
April 3, 2025
ORLANDO, Fla., April 03, 2025 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) previously reported that it needed additional time to complete its audit of the Annual Report on Form 10-K for the year-end …
BetterLife Pharma Appoints Corporate Advisor
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed André Beaudry as Corporate …
Press Release for Early Warning Report Regarding Prosper Gold Corp.
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- Peter Bernier, President and Chief Executive Officer of Prosper Gold Corp. (“Prosper” or the “Company”), announced that on April 2, 2025, Mr. Bernier (the “Acquiror”) purchased 4,000,000 …
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
GlobeNewswire
·
April 3, 2025
- The oversubscribed private financing round, with primary participation from Fidelity Management …
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
GlobeNewswire
·
April 3, 2025
MOUNTAIN VIEW, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, will be attending and presenting at the upcoming American Academy of …
Good Earth Oils Canola Oil Now Available on JD.com
GlobeNewswire
·
April 3, 2025
COOTAMUNDRA, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT) today announced Good Earth Oils (GEO) premium quality canola oil has successfully entered the …
Love on Tap: Heineken® Launches Dating App for Bars to Help Young Adults Spice Up Their Social Lives
GlobeNewswire
·
April 3, 2025
Heineken® has unveiled apps in Italy and Brazil that will help young adults find bars the same way they prefer to find love: through swiping Global data shows that 67% of young adults* tend to go back to the same bar time again, despite wanting now more …
TerrAscend to Host First Quarter 2025 Earnings Conference Call
GlobeNewswire
·
April 3, 2025
TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it will host a scheduled conference call to discuss the results for its …
Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa
GlobeNewswire
·
April 3, 2025
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the Committee for Medicinal Products …
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
GlobeNewswire
·
April 3, 2025
-- Novel, locally administered gene therapy designed to boost cellular production of anti-inflammatory protein IL-1Ra in the knee -- -- Initial topline results from two-part, randomized, double-blind, active-controlled study expected late 2026 -- BRISBANE, …
BigCommerce and Feedonomics Announce Winners of EMEA Customer and Partner Awards to Honor Exceptional Contributions in Ecommerce
GlobeNewswire
·
April 3, 2025
AUSTIN, Texas and LONDON, April 03, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands and retailers, today announced the winners of the 2025 BigCommerce and Feedonomics …
Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN
GlobeNewswire
·
April 3, 2025
On track to announce primary endpoint result from ORIGIN 3 trial this quarter (2Q 2025) U.S. FDA BLA submission for accelerated approval planned for 2H 2025 BRISBANE, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late …
ZenaTech Closes Second Southeast Region Acquisition, Wallace Surveying Corporation, Set to Become the Third Acquisition to Power Its National Drone as a Service (DaaS) Business
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone-as-a-Service (DaaS), enterprise SaaS and …
CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
ZUG, Switzerland and BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior …
aTyr Pharma to Participate in April Investor Conferences
GlobeNewswire
·
April 3, 2025
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that …
Accelerating our Customer-First Strategy with Industry-Leading 3-Year Price Lock and Free Phone Guarantee for Everyone
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Verizon today announced the next evolution of its multi-year consumer business transformation, with a strong value commitment designed to strengthen long-term customer relationships across its mobile and home …
Enphase Energy Adds Battery Backup to Boost Resilience in France and the Netherlands
GlobeNewswire
·
April 3, 2025
FREMONT, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the introduction of the IQ® …
March Commercial Chapter 11s Increase 20 Percent from Previous Year
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Commercial chapter 11 bankruptcy filings increased 20 percent in March 2025, with filings climbing to 733 from the 611 filings registered in March 2024, according to data provided by Epiq AACER, the leading …
American Rebel Holdings, Inc. (NASDAQ: AREB) Invites Patriotic Investors, Fans, and Beer Enthusiasts to Celebrate Freedom with a New Video Release Highlighting the American Rebel Story
GlobeNewswire
·
April 3, 2025
Watch the American Rebel Story and learn about America’s Next Great Company as told by CEO Andy Ross Nashville, TN, April 03, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB), the creator of American Rebel Beer and champion of …